These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 25637705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery.
    Chen KJ, Liang HF, Chen HL, Wang Y, Cheng PY, Liu HL, Xia Y, Sung HW.
    ACS Nano; 2013 Jan 22; 7(1):438-46. PubMed ID: 23240550
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C, Wang X, Zhong T, Zhao Y, Zhang WQ, Ren W, Huang D, Zhang S, Guo Y, Yao X, Tang YQ, Zhang X, Zhang Q.
    Int J Nanomedicine; 2015 Jan 22; 10():2229-48. PubMed ID: 25834435
    [Abstract] [Full Text] [Related]

  • 9. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.
    Liang X, Wang Y, Shi H, Dong M, Han H, Li Q.
    Int J Nanomedicine; 2021 Jan 22; 16():2569-2584. PubMed ID: 33833512
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles.
    Li X, Yu Y, Ji Q, Qiu L.
    Nanomedicine; 2015 Jan 22; 11(1):175-84. PubMed ID: 25218928
    [Abstract] [Full Text] [Related]

  • 12. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR, Paliwal R, Pal HC, Saxena AK, Sharma PR, Gupta PN, Agrawal GP, Vyas SP.
    Mol Pharm; 2012 Jan 01; 9(1):176-86. PubMed ID: 22091702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.
    Teymouri M, Farzaneh H, Badiee A, Golmohammadzadeh S, Sadri K, Jaafari MR.
    Eur J Pharm Sci; 2015 Dec 01; 80():66-73. PubMed ID: 26299343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q.
    Yao Xue Xue Bao; 2005 May 01; 40(5):475-80. PubMed ID: 16220797
    [Abstract] [Full Text] [Related]

  • 17. Dual-targeting nanocarrier system based on thermosensitive liposomes and gold nanorods for cancer thermo-chemotherapy.
    Yu M, Guo F, Tan F, Li N.
    J Control Release; 2015 Oct 10; 215():91-100. PubMed ID: 26256259
    [Abstract] [Full Text] [Related]

  • 18. Photosensitizer-Doped and Plasma Membrane-Responsive Liposomes for Nuclear Drug Delivery and Multidrug Resistance Reversal.
    Zhu YX, Jia HR, Duan QY, Liu X, Yang J, Liu Y, Wu FG.
    ACS Appl Mater Interfaces; 2020 Aug 19; 12(33):36882-36894. PubMed ID: 32666795
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.